Work Here?
Overview
Genomics England works with the NHS to bring genomic healthcare and research to Britain, including genomic testing as part of routine care and the data/tech researchers need. It runs a national program to collect and analyze genetic data, comparing genomes to support diagnosis, treatment, and prevention and to power discoveries. Its approach combines a government-backed national effort with NHS clinical care, building a large, unique genomic dataset and turning findings into real-world tools. Its goal is to bring genomic healthcare to everyone who needs it, while speeding up research and enabling more precise treatments.
About Genomics England
Industries
Data & Analytics
Healthcare
Company Size
501-1,000
Company Stage
N/A
Total Funding
N/A
Headquarters
London, United Kingdom
Founded
2013
Your Connections
People at Genomics England who can refer or advise you
Simplify's Take
What believers are saying
- Whole-genome sequencing demand supports expansion in rare disease and cancer.
- Self-service research tools broaden use by technical and non-technical users.
- HDRS leadership overlap strengthens UK health-data coordination opportunities.
What critics are saying
- Blackwood’s 2026 departure leaves an unresolved succession gap at chair level.
- AWS and LifeBit dependence exposes research workflows to vendor disruptions.
- Data-trust failure would damage participant recruitment and NHS research legitimacy.
What makes Genomics England unique
- Government-owned platform linking NHS genomics with national research infrastructure.
- Deep partnerships across NHS, AWS, Seqera Labs, and Revvity.
- Leadership under Rich Scott and Nicola Blackwood emphasized participant trust.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
Health Savings Account/Flexible Spending Account
Unlimited Paid Time Off
Flexible Work Hours
Remote Work Options
Paid Vacation
Paid Sick Leave
Paid Holidays
Sabbatical Leave
Hybrid Work Options
Stock Options
Company Equity
401(k) Retirement Plan
401(k) Company Match
Performance Bonus
Profit Sharing
Employee Stock Purchase Plan
Relocation Assistance
Employee Referral Bonus
Student Loan Assistance
Parental Leave
Family Planning Benefits
Fertility Treatment Support
Adoption Assistance
Childcare Support
Elder Care Support
Pet Insurance
Bereavement Leave
Professional Development Budget
Conference Attendance Budget
Training Programs
Tuition Reimbursement
Professional Certification Support
Mentorship Program
Wellness Program
Mental Health Support
Gym Membership
Commuter Benefits
Meal Benefits
Phone/Internet Stipend
Home Office Stipend
Legal Services
Employee Discounts
Company Social Events
Company News
Genomics England has announced the appointment of Julian Thomas into the new role of Chief Technology and Product Officer.
WALTHAM, Mass.-(BUSINESS WIRE)- Revvity, Inc. (NYSE: RVTY), today announced an expansion of its work with Genomics England that leverages both organizations' expertise and resources to advance critical genomic initiatives across the United Kingdom.
Genomics England, a genetic testing company that partners with the National Institutes of Health, is using advanced computing through AWS to improve the diagnosis of rare diseases.
In particular, the establishment of a Yellow Card biobank by Genomics England in collaboration with MHRA, underscores the proactive measures taken by key industry players to integrate genetic information with pharmacovigilance data.
Genomics England announces appointment of Dr Rich Scott as Interim Chief Executive Officer.
Genomics England is Hiring for 6 Jobs on Simplify!
Find jobs on Simplify and start your career today
About Genomics England
Industries
Data & Analytics
Healthcare
Company Size
501-1,000
Company Stage
N/A
Total Funding
N/A
Headquarters
London, United Kingdom
Founded
2013
Genomics England is Hiring for 6 Jobs on Simplify!
Find jobs on Simplify and start your career today